FIGURE 2.

Association between use of chlorprothixene, diabetes and major adverse cardiovascular events in subgroups of the high‐dimensional propensity score‐matched cohort. Results from as‐treated analyses. Analyses with diabetes as outcome additionally adjusted for history of dementia. Analyses of major adverse cardiovascular events additionally adjusted for history of major depression. Abbreviations: CHL: chlorprothixene, CI: confidence interval, HR: hazard ratio, IR: incidence rate (events per 1000 person‐years), QUE: quetiapine